Restricting carbohydrates to fight head and neck cancer—is this realistic?
Open Access
- 1 September 2014
- journal article
- review article
- Vol. 11 (3) , 145-161
Abstract
Head and neck cancers (HNCs) are aggressive tumors that typically demonstrate a high glycolytic rate, which results in resistance to cytotoxic therapy and poor prognosis. Due to their location these tumors specifically impair food intake and quality of life, so that prevention of weight loss through nutrition support becomes an important treatment goal. Dietary restriction of carbohydrates (CHOs) and their replacement with fat, mostly in form of a ketogenic diet (KD), have been suggested to accommodate for both the altered tumor cell metabolism and cancer-associated weight loss. In this review, I present three specific rationales for CHO restriction and nutritional ketosis as supportive treatment options for the HNC patient. These are (1) targeting the origin and specific aspects of tumor glycolysis; (2) protecting normal tissue from but sensitizing tumor tissue to radiation- and chemotherapy induced cell kill; (3) supporting body and muscle mass maintenance. While most of these benefits of CHO restriction apply to cancer in general, specific aspects of implementation are discussed in relation to HNC patients. While CHO restriction seems feasible in HNC patients the available evidence indicates that its role may extend beyond fighting malnutrition to fighting HNC itself.Keywords
This publication has 101 references indexed in Scilit:
- Definition and classification of cancer cachexia: an international consensusThe Lancet Oncology, 2011
- Mitochondrial DNA mutations in head and neck cancer are infrequent and lack prognostic utilityBritish Journal of Cancer, 2011
- Regulation of global genome nucleotide excision repair by SIRT1 through xeroderma pigmentosum CProceedings of the National Academy of Sciences, 2010
- HIF-1: upstream and downstream of cancer metabolismCurrent Opinion in Genetics & Development, 2010
- Is Akt the “Warburg kinase”?—Akt-energy metabolism interactions and oncogenesisSeminars in Cancer Biology, 2009
- Increased levels of superoxide and H2O2 mediate the differential susceptibility of cancer cells versus normal cells to glucose deprivationBiochemical Journal, 2009
- Glucose as a prognostic factor in ovarian carcinomaCancer, 2009
- Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapyProceedings of the National Academy of Sciences, 2008
- AKT/PKB Signaling: Navigating DownstreamCell, 2007
- Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neckProceedings of the National Academy of Sciences, 2007